Back to Search
Start Over
REDUCED LEVELS OF SHP1 PROVIDES AN ADDITIVE SURVIVAL ADVANTAGE TO THE PH+ CELLS OF CML PATIENTS AND MAY ACCOUNT FOR RESISTANCE TO IMA TREATMENT
- Source :
- (2009)., info:cnr-pdr/source/autori:Esposito, N; Colavita, I; Izzo, B; Quarantelli, F; Sica, RA; Buonomo, T; Roberti, V; Luciano, L; Del Vecchio, L; Peluso, A; Melo, JV; Russo, D; Martinelli, G; Martinelli, R; Ruoppolo, M; Pane, F/titolo:REDUCED LEVELS OF SHP1 PROVIDES AN ADDITIVE SURVIVAL ADVANTAGE TO THE PH+ CELLS OF CML PATIENTS AND MAY ACCOUNT FOR RESISTANCE TO IMA TREATMENT/doi:/rivista:/anno:2009/pagina_da:/pagina_a:/intervallo_pagine:/volume
- Publication Year :
- 2009
Details
- Database :
- OpenAIRE
- Journal :
- (2009)., info:cnr-pdr/source/autori:Esposito, N; Colavita, I; Izzo, B; Quarantelli, F; Sica, RA; Buonomo, T; Roberti, V; Luciano, L; Del Vecchio, L; Peluso, A; Melo, JV; Russo, D; Martinelli, G; Martinelli, R; Ruoppolo, M; Pane, F/titolo:REDUCED LEVELS OF SHP1 PROVIDES AN ADDITIVE SURVIVAL ADVANTAGE TO THE PH+ CELLS OF CML PATIENTS AND MAY ACCOUNT FOR RESISTANCE TO IMA TREATMENT/doi:/rivista:/anno:2009/pagina_da:/pagina_a:/intervallo_pagine:/volume
- Accession number :
- edsair.dedup.wf.001..02601249b5c7a5c6d820039f6d659482